To better understand the role PACAP-responsive receptors, especially the PAC1 receptor, play in migraine and headache disorders and realize the therapeutic benefit of targeting this receptor family, a more comprehensive understanding of their expression is required. This evidence concerns the gene ADCYAP1R1 and migraine disorder.